SANUWAVE Health, Inc.
General ticker "SNWV" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $204.4M (TTM average)
SANUWAVE Health, Inc. does not follow the US Stock Market performance with the rate: -34.4%.
Estimated limits based on current volatility of 4.3%: low 5.08$, high 5.54$
Factors to consider:
- Total employees count: 55 (+19.6%) as of 2025
- US accounted for 99.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Liquidity and credit risks, Internal control weaknesses, Regulatory and compliance, Product liability claims, Manufacturing capacity
- Current price 63.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [13.69$, 32.53$]
- 2026-12-31 to 2027-12-31 estimated range: [9.26$, 23.17$]
Financial Metrics affecting the SNWV estimates:
- Positive: with PPE of -189.5 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 1.49 <= 2.37
- Negative: Shareholder equity ratio, % of 4.34 <= 7.04
- Negative: negative Industry operating cash flow (median)
- Negative: 0.47 < Industry inventory ratio change (median), % of 0.70
- Positive: 7.80 < Operating profit margin, % of 11.23
- Negative: negative Industry operating income (median)
Short-term SNWV quotes
Long-term SNWV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $20.40MM | $32.63MM | $44.05MM |
| Operating Expenses | $20.94MM | $27.22MM | $39.11MM |
| Operating Income | $-0.54MM | $5.42MM | $4.95MM |
| Non-Operating Income | $-25.26MM | $-36.76MM | $6.95MM |
| Interest Expense | $15.62MM | $13.64MM | $6.25MM |
| R&D Expense | $0.58MM | $0.67MM | $1.35MM |
| Income(Loss) | $-25.80MM | $-31.34MM | $11.90MM |
| Taxes | $0.00MM | $0.03MM | $0.09MM |
| Net Income(Loss)* | $-25.81MM | $-31.37MM | $11.81MM |
| Stockholders Equity | $-43.18MM | $-15.79MM | $1.62MM |
| Inventory | $2.95MM | $4.15MM | $5.93MM |
| Assets | $22.42MM | $30.12MM | $37.34MM |
| Operating Cash Flow | $-4.54MM | $2.46MM | $3.88MM |
| Capital expenditure | $0.00MM | $0.49MM | $1.94MM |
| Investing Cash Flow | $0.02MM | $-0.49MM | $3.43MM |
| Financing Cash Flow | $5.21MM | $6.35MM | $-5.59MM |
| Earnings Per Share** | $-12.19 | $-7.03 | $1.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.